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Abstract
Background: The changes occurring in the rodent uterus after parturition can be used as a model of
extensive tissue remodeling. As the uterus returns to its prepregnancy state, the involuting uterus
undergoes a rapid reduction in size primarily due to the degradation of the extracellular matrix,
particularly collagen. Membrane type-I matrix metalloproteinase (MT1-MMP) is one of the major
proteinases that degrades collagen and is the most abundant MMP form in the uterus. Matrix
metalloproteinase-2(MMP-2) can degrade type I collagen, although its main function is to degrade type IV
collagen found in the basement membrane. To understand the expression patterns of matrix
metalloproteinases (MMPs) in the rat uterus, we analyzed their activities in postpartum uterine involution.
Methods: We performed gelatin zymography, northern blot analysis and immunohistochemistry to
compare the expression levels of MT1-MMP, MMP-2, matrix metalloproteinase-9 (MMP-9) and the tissue
inhibitors of MMPs-1 and 2 (TIMP-1 and TIMP-2) in the rat uterus 18 h, 36 h and 5 days after parturition
with their expression levels during pregnancy (day 20).
Results: We found that both MT1-MMP and MMP-2 localized mainly in the cytoplasm of uterine
interstitial cells. The expression levels of MT1-MMP and MMP-2 mRNAs and the catalytic activities of the
expressed proteins significantly increased 18 h and 36 h after parturition, but at postpartum day 5, their
mRNA expression levels and catalytic activities decreased markedly. The expression levels of MMP-9
increased 18 h and 36 h after parturition as determined by gelatin zymography including the expression
levels of TIMP-1 and TIMP-2.
Conclusion: These expression patterns indicate that MT1-MMP, MMP-2, MMP-9, TIMP-1 and TIMP-2
may play key roles in uterine postpartum involution and subsequent functional regenerative processes.
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During pregnancy, the uterus enlarges, which in rats is
mainly caused by an increase in the amount of collagen
and hypertrophy of the uterine smooth muscle cells. After
parturition, the uterus undergoes involution during
which it returns to its prepregnancy state. Matrix metallo-
proteinases (MMPs) are a group of structurally related
endopeptidases that catalyze the degradation of various
macromolecular components of the extracellular matrix
and basement membrane [1,2], and induce various forms
of tissue remodeling, including wound healing [3,4], tro-
phoblast invasion [5,6], organ morphogenesis [7,8], and
uterine [9-11], mammary gland [12,13], and prostate
gland [14,15] involution. We previously reported that an
increase in the expression levels of both membrane type
1-MMP (MT1-MMP) and MMP-2 plays a key role in tissue
remodeling during corpus luteum structural involution
both in rats and humans [16-18].
To obtain additional information on the activity of MMPs
during uterine involution, we have initiated studies using
a rat model to examine MMP expression and function in
the uterus during pregnancy and after parturition.
Although MT1-MMP is abundant in the uterus [19,20], lit-
tle is known about its activity or that of MMP-2 during
uterine involution. To the reason for this, we investigated
the expression patterns of MT1-MMP, MMP-2, MMP-9,
TIMP-1 and TIMP-2 and the activation of MMP-2 in the
rat uterus during postpartum involution.
Materials and methods
Rat uterus
Pregnant Sprague-Dawley rats were obtained from
Hokudo Co., (Sapporo, Japan) on day 17 of gestation,
after which they were kept in our laboratory and main-
tained on a 12-hour light and 12-hour dark regimen (light
7:00–19:00) with free access to water and a standard diet.
Uterine tissue for postpartum involution analysis was
obtained from five rats per group on gestation day 20 and
then 18 h, 36 h and 5 days after parturition. The Animal
Care and Use Committee of the Sapporo Medical Univer-
sity School of Medicine approved all procedures of this
study, which are in accordance with the standards
described in the National Institutes of Health Guide for
Care and Use of Laboratory Animals.
Each uterine tissue sample was divided into two pieces.
One piece was fixed in 4% paraformaldehyde/PBS and
embedded in paraffin for immunohistological analysis.
The other was used for biochemical studies (zymography
and northern blotting); all tissue samples were frozen on
dry ice and then stored at -80°C until use.
Chemicals
Ultraspec RNA was purchased from Biotex Laboratories,
Inc. (Houston, TX); 3,3'-diaminobenzidine (DAB) was
purchased from Katayama Chemical (Osaka, Japan);
Nytran-Plus was purchased from Schleicher & Schuell
(Keene, NH); 32P-dCTP and a Nick column were pur-
chased from Amersham Pharmacia Biotech (Buckingham-
shire, England); Prime-It II random primer labeling kits
were purchased from Stratagen (La Jolla, CA); rabbit anti-
rat MT1-MMP antiserum and anti-MMP-2 antibodies
were purchased from Fuji Chemical Industries, Ltd.
(Toyama, Japan); biotinylated antibodies and Vectastain
ABC Elite kits were purchased from Vector Laboratories
(Burlingame, CA); fetal calf serum (FCS) was purchased
from Gibco (Grand Island, NY); APS-coated glass slides
were purchased from Matsunami (Tokyo, Japan); STUF
solution was purchased from Serotec Ltd. (Kidlington,
Oxford, UK); and Block Ace was purchased from Dainip-
pon Pharmaceutical Co. (Osaka, Japan).
Northern blotting
Total RNA was extracted from uterine tissue samples using
an Ultraspec RNA isolation system, after which the
extracted RNA (20 μg/lane) was electrophoresed on 1%
agarose/formaldehyde gels (100 V; 2 h), transferred over-
night onto nylon membranes in 20 × SSC (3 M sodium
chloride, 0.3 M trisodium citrate) and fixed using a UV
linker. Filters were prehybridized for 4 h and then hybrid-
ized overnight at 42°C with a 32P-labeled cDNA probe.
The probes used for Northern blotting were a 1.2-kb Hind-
III- and EcoR-digested fragment of MT1-MMP cDNA, a
1.5-kb EcoRI- and Bam-HI- digested fragment of MMP-2
cDNA, a 0.6-kb Cla-I- and Bam-HI-digested fragment of
TIMP-1 cDNA, and a 0.7-kb Eco-RI- and Bg-II-digested
fragment of TIMP-2 cDNA [21]. A 450-bp cDNA fragment
encoding the ribosomal protein L38 was used as an inter-
nal control [22].
The probes were radiolabeled with 32P-dCTP using
Prime-It II random primer labeling kits, after which the
labeled probes were purified on a Nick column before
hybridization. After hybridization, the filters were washed
four times: twice for 15 min each with 2 × SSC containing
0.1% SDS at room temperature, and twice for 15 min each
with 0.2 × SSC containing 0.1% SDS at 65°C. The filters
were then exposed to a Fuji RX X-ray film at -70°C for 1–
2 days.
Gelatin zymography
Gelatin zymography was carried out as previously
described [16]. Briefly, uterine samples were homoge-
nized (100 mg wet weight/ml of PBS containing 0.2% Tri-
ton X-100) using a Teflon glass tissue grinder on ice (15
strokes). The resulting homogenates were centrifuged at
12,000 × g for 20 min at 4°C, after which the supernatantsPage 2 of 7
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protein concentration, aliquots of the extract (40 μg of
protein) were electrophoresed in 10% polyacrylamide
gels containing 1 mg/ml gelatin.
Gelatin zymography using crude membrane fraction from 
rat uterus
The crude membrane fraction from the rat uterus was iso-
lated as previously reported [17,23]. Briefly, uterine tissue
samples were homogenized in 2 ml of Tris buffer contain-
ing 0.25 M sucrose using a Teflon glass tissue grinder at 45
× g on ice. The resulting homogenates were filtered
through a nylon mesh (42 μm) and centrifuged at 120 × g
for 10 min. The supernatant was then collected and cen-
trifuged at 10,000 × g for 30 min at 4°C, and the pellet
was collected as the crude membrane fraction and stored
at -80°C until use. To examine the expression level of
membrane-bound pro-MMP-2, aliquots of the crude uter-
ine membrane fraction (20 μg) were mixed with 1 μl of
FCS as a source of procollagenase and incubated for 2 h at
37°C. After terminating the procollagenase activity by
adding of the sample buffer, the expression level of mem-
brane-bound pro-MMP-2 as estimated from the liberated
MMP-2 activity as determined by gelatin zymography.
Immunohistochemistry
The uterine tissues embedded in paraffin were cut into 5-
μm-thick sections and mounted on APS-coated glass
slides. The sections were then deparaffinized with xylene
and the slides were placed on a hot plate at 90°C, covered
with a STUF solution for 10 min, and then rinsed several
times with PBS. Endogenous peroxidase activity was
blocked by incubating the slides in 0.6% H2O2 in metha-
nol for 30 min at room temperature, after which Block Ace
was applied for 30 min at room temperature to minimize
nonspecific antibody binding. Primary antibodies were
then applied to the sections for 60 min at room tempera-
ture, after which the sections were incubated with a bioti-
nylated secondary antibody for 30 min. The sections were
then stained using the ABC method with DAB as a sub-
strate; hematoxylin and eosin stain was used as the coun-
terstain. As a negative control, the slides were processed
without incubation with primary antibodies. The sections
were also stained with hematoxylin and eosin.
Densitometry
Bands showing gelatinase activity were analyzed using
NIH Image software (Version 1.61). Bands on Northern
blots were analyzed using a BAS 2000 Bio-Imaging Ana-
lyzer (FUJI, Tokyo, Japan). Radioactivity was normalized
to that in the L38 RNA band.
Statistical analysis
Data are presented as mean ± SEM. The differences
between groups were evaluated using one-way ANOVA
with post hoc Schaffer's F-test and unpaired Student's t-
test. Values of P < 0.05 were considered significant.
Results
Time-dependent localization of MMP-2 and MT1-MMP 
proteins in rat uterus
Immunohistochemical staining revealed that both MT1-
MMP and MMP-2 proteins mainly localized in the cyto-
plasm of uterine interstitial cells 18 h (not shown) and 36
h after parturition, although uterine smooth muscle cells
also showed weak MMP-2 protein staining (Fig. 1). Weak
MMP-2 protein staining was also generally observed in
the uterine tissue on day 5 after parturition, and a weaker
MMP-2 protein staining was observed in the uterine tissue
from 20-day pregnant rats.
Immunohistochemical analysis of rat uterusFigure 1
Immunohistochemical analysis of rat uterus. (Top row) 
Hematoxylin and eosin (HE) staining of rat uterus: (A) 20 
days pregnant; (B) 36 h after parturition; (C) 5 days after par-
turition. (Middle and bottom rows) Immunohistochemical 
localizations of MMP-2 (middle) and MT1-MMP (bottom): (D, 
G) 20 days pregnant; (E, H) 36 h after parturition; (F, I) 5 
days after parturition. Both MMP-2 and MT1-MMP are 
strongly stained in the interstitial cells at 36 h and weakly 
stained 5 days after parturition. Original magnification ×175, 
scale bar = 25 μm.Page 3 of 7
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TIMP-2 mRNAs in rat uterus
As shown in Fig. 2, the uterine expression levels of both
MMP-2 and MT1-MMP mRNAs time-dependently
increased for at least 36 h after parturition, with larger
increases observed in the MT1-MMP expression level. The
expression levels then decreased markedly 5 days after
parturition, although they remained above the levels
expressed in the uterine tissue from pregnant rats. The
expression level of TIMP-1 mRNA reached a peak within
18 h, the earliest time point measured. In contrast, the
expression level of TIMP-2 mRNA increased only slightly
18 h and 36 h after parturition, but markedly higher
expression levels were observed 5 days after parturition.
Gelatinase activity in extracts of rat uterus
Gelatinase activity in uterine tissue extracts was examined
by gelatin zymography (Fig. 3). In zymograms generated
using uterine samples from pregnant (20 days) rats, most
of the gelatinase activity was found in a 68-kDa band,
with a lower activity in an approximately 62-kDa band.
Treatment with EDTA/orthophenanthroline eliminated
the activity, whereas pretreatment with amino phenyl
Zymography of homogenate extract from rat uterusFigure 3
Zymography of homogenate extract from rat uterus. (a) Rep-
resentative zymogram showing gelatinase activity of indicated 
enzyme in uterine tissue harvested at indicated times. Note 
that in the uterine tissues from pregnant rats, the expression 
of 68-kDa pro-MMP-2 predominated, whereas the expres-
sion of 62-kDa active MMP-2 predominated postpartum. (b) 
Densitometric analysis of zymograms showing relative gelati-
nase activity. Bars represent mean ± SEM (n = 5); a, P < 0.01 
vs 18 h, 36 h and 5 days after parturition; b, P < 0.05 vs 36 h 
after parturition; c, P < 0.01 vs 18 h and 36 h after parturition 
(20 days pregnant, 20D; 18 h after parturition, 18H; 36 h 
after parturition, 36H; and 5 days after parturition, 36 D).
Expression levels of MT1-MMP, MMP-2, TIMP-1 and TIMP-2 mRNA  in rat uterusFigure 2
Expression levels of MT1-MMP, MMP-2, TIMP-1 and TIMP-2 
mRNAs in rat uterus. (a) Representative Northern blot 
showing expression of indicated mRNA in uterine tissue har-
vested at indicated times. (b) Densitometric analysis of 
Northern blots showing relative mRNA expression levels of 
MMP-2, MT1-MMP, TIMP-1 and TIMP-2. Bars represent 
mean ± SEM (n = 5); a, P < 0.01 vs 18 h, 36 h and 5 days after 
parturition; b, P < 0.05 vs 5 days after parturition; c, P < 0.01 
vs 5 days after parturition, d, P < 0.01 vs 18 h after parturi-
tion; e, P < 0.05 vs 36 h and 5 days after parturition; f, P < 
0.05 vs 18 h and 36 h after parturition; g, P < 0.01 vs 5 days 
after parturition; h, P < 0.05 vs 18 h and 36 h after parturi-
tion. (20 days pregnant, 20D; 18 h after parturition, 18H; 36 
h after parturition, 36H; and 5 days after parturition, 36 D)Page 4 of 7
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genase, elicited a marked shift in the activity from the 68-
kDa band to the 62-kDa band (data not shown).
Although not all MMPs exhibit gelatinase activity, which
enables MMPs to be detected by zymography, we sus-
pected that the major MMPs in the uterine tissue extracts
from the pregnant rats were MMP-2 and MMP-9, which
are present mainly as pro-MMP-2, the 68-kDa precursor of
the 62-kDa activated form of MMP-2, and MMP-9, the 92-
kDa. After parturition, however, the expression level of
activated MMP-2 increased significantly over time corre-
sponding to the expression level of MMP-2 mRNA,
whereas the expression level of pro-MMP-2 remained
unchanged (Fig. 3). The expression level of MMP-9
increased 18 h and 36 h after delivery.
Expression levels of pro-MMP-2 in uterine plasma 
membrane fractions
The expression levels of pro-MMP-2 in the plasma mem-
brane fractions of the rat uterus were estimated from
MMP-2 activity induced by incubation with FCS as a
source of procollagenase and revealed by zymography. As
shown in Fig. 4, the levels of expression and gelatinase
activity of activated MMP-2 paralleled those of both MT1-
MMP mRNA expression and the gelatinase activity of
MMP-2 in the uterine tissue extract.
Discussion
Immunohistochemical staining revealed that both MT1-
MMP and MMP-2 proteins mainly localized in the cyto-
plasm of the uterine interstitial cells 18 h (not shown) and
36 h after parturition. Moreover, MMP-2 mRNA and MT1-
MMP mRNA expressen levels time-dependently increased
for at least 36 h. The level of the 62-kDa activated form of
MMP-2 also increased 18 h and 36 h after parturition. The
expression levels of gelatinase activity of the uterine tissue
extract in the uterine plasma membrane fraction increased
18 h and 36 h after parturition. These results indicate that
MMP-2 and MT1-MMP may play key roles in uterine post-
partum involution
During pregnancy, the uterus is transformed into a large
muscular organ sufficient to accommodate the fetus, pla-
centa and amniotic fluid. After parturition, the uterus
undergoes involution, a conspicuous feature character-
ized by the rapid decrease in the amount of collagen
resulting from the extracellular degradation of collagen
bundles. Activated collagenases cleave the collagen bun-
dles into fragments, which then denature at body temper-
ature into gelatin. Gelatinases then cleave the gelatin in
small peptides that are rapidly removed in the blood
stream [24]. To better understand the functions of MMPs
in various uterine processes, we have initiated studies
using a rat model for studying the activities of various
MMPs in the uterus during pregnancy and after parturi-
tion. MT1-MMP, for example, has various functions that
include the degradation of several types of collagen, the
activations of other MMPs and activities related to apop-
tosis. This study showed that the expression levels of MT1-
MMP and MMP-2 were significantly increased in the cyto-
plasm of uterine interstitial cells in the first five days after
parturition, which suggests that these two enzymes play
important roles in the postpartum involution of the
enlarged uterus in rats. Various of MMPs are reportedly
involved in tissue remodeling during postpartum uterine
involution. Stygar et al. reported that cervical stromal
fibroblasts and smooth muscle cells were identified as the
main sources of MMP-2, whereas MMP-9 protein was
observed only in invading leukocytes. MMP-2 and MMP-
Expression level of membrane-bound Pro-MMP-2 in uterine tissu  as rev aled by zymography of crude uterine cell mem-bran fractionFig re 4
Expression level of membrane-bound Pro-MMP-2 in uterine 
tissue as revealed by zymography of crude uterine cell mem-
brane fraction. (a) Representative zymogram obtained after 
exposing samples of crude uterine cell membrane fraction 
isolated from uterine tissue harvested at indicated times to 
FCS as source of procollagenase. (b) Densitometric analysis 
of zymograms showing relatively induced gelatinase activity. 
Bars represent mean ± SEM (n = 5); a, P < 0.01 vs 18 h and 
36 h after parturition; b, P < 0.05 vs 5 days after parturition; 
c, P < 0.05 vs 36 h after parturition; d, P < 0.05 vs 18 h and 
36 h after parturition (20 days pregnant, 20D; 18 h after par-
turition, 18H; 36 h after parturition, 36H; and 5 days after 
parturition, 36 D)Page 5 of 7
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Lyons et al. reported that MMP-9 may be involved in pre-
term labor, cervical maturity, and postpartum uteruine
involution [26]. Roh et al. reported that the proMMP-9 in
the uterine tissue maybe related to the remodelling of
human myometrium during labor [27]. We also consider
that MMP-9 is related to postpartum uterine involution
from the results of our gelatine zymograpy experiment
(Fig. 3(a)).
Evidence suggests that MT1-MMP causes the degradation
of collagen types I, IV and V and elastin [28,29], and acti-
vates membrane-bound pro-MMP-2 [30-33]. Although it
is thought that the main function of the activated MMP-2
is the degradation of type IV collagen in the basement
membrane, it also cleaves type I collagen [34], which is
consistent with the finding that during postpartum uter-
ine involution, MT1-MMP and MMP-2 act together to
degrade the abundant type I collagen.
We found that the time courses of the expressions of
MMP-2, TIMP-1 and TIMP-2 differed from those
described in the reports mentioned above. This difference
is reflected in part by the transiently high expression level
of TIMP-1 observed 18 h after parturition. Because TIMP-
1 is known to bind stoichiometrically to almost all MMP
active sites, thereby irreversibly inhibiting the enzyme's
activity [33,35], its upregulation would be expected to
mitigate the effect of the abrupt concurrent increase in
MMP expression level. On the other hand, the suppres-
sion of TIMP-1 transcription 36 h after parturition would
likely contribute to the maintenance of a high MMP activ-
ity.
In contrast to TIMP-1, TIMP-2 transcription was enhanced
only slightly 5 days after parturition. Although TIMP-2
exerts a strong inhibitory effect on MMPs similar to TIMP-
1 [36], it also forms MT1-MMP/TIMP-2 and MT1-MMP/
TIMP-2/pro-MMP-2 complexes, which are involved in the
activation of pro-MMP-2 [37-39]. This suggests that at 18
h and 36 h postpartum the slight increase in TIMP-2
expression level induced proMMP-2 activation. In con-
trast, the much larger increase in TIMP-2 expression level
observed 5 days after parturition, which coincides with
the decrease in the activities of MT1-MMP and MMP-2,
mediated pro-MMP-2 suppression. Taken together, these
findings strongly suggest that MT1-MMP, MMP-2 and
MMP-9 are time-dependently regulated and play impor-
tant roles in tissue remodeling during postpartum uterine
involution.
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